Utility of urinary type I collagen cross-linked N-telopeptide as a prognostic indicator in breast cancer patients with bone metastases.

CONCLUSION: We demonstrated that the u-NTX change ratio in denosumab-treated breast cancer patients with bone metastases can be a prognostic marker. PMID: 32415556 [PubMed - as supplied by publisher]

https://www.ncbi.nlm.nih.gov/pubmed/32415556?dopt=Abstract

Source: Breast Cancer - May 14, 2020 Category: Cancer & Oncology Authors: Shizuku M, Shibata M, Okumura M, Takeuchi D, Kikumori T, Mizuno Y Tags: Breast Cancer Source Type: research